Compare ARAY & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARAY | DRIO |
|---|---|---|
| Founded | 1990 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.5M | 84.1M |
| IPO Year | 2007 | N/A |
| Metric | ARAY | DRIO |
|---|---|---|
| Price | $0.60 | $10.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $3.50 | ★ $50.00 |
| AVG Volume (30 Days) | ★ 782.5K | 9.0K |
| Earning Date | 02-04-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $436,969,000.00 | $24,732,000.00 |
| Revenue This Year | $3.82 | N/A |
| Revenue Next Year | $4.08 | $7.64 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.29 |
| 52 Week Low | $0.56 | $5.94 |
| 52 Week High | $2.95 | $17.74 |
| Indicator | ARAY | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 22.22 | 37.11 |
| Support Level | $0.56 | $9.94 |
| Resistance Level | $0.83 | $11.13 |
| Average True Range (ATR) | 0.05 | 0.64 |
| MACD | -0.01 | -0.16 |
| Stochastic Oscillator | 17.06 | 5.88 |
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.